Varian Medical Systems CEO and leadership

Joined Varian as an intern in 1999, then full time in 2001, and has held multiple cross-functional roles and executive positions during two-decade tenure with the company.

Intimate understanding of healthcare, software solutions, medical devices, technology trends, reimbursement trends and strategies that lead to success in targeted channel segments globally. Marketing strategy, new product launch, portfolio strategy, M&A, P&L, restructuring, government relations, and general management experience.

Consistent creation of strategies and execution against operating plans, sales goals and market objectives, including extensive experience of both high growth and slow growth periods (turnaround plans) of Varian Medical Systems journey from $500M to over $3B. Including returning Varian to double digit growth following becoming President of the $3B+ P&L of Oncology systems.

Strong leadership skills with a track record of creating an inspiring vision and communicating effectively both internally/externally through developing cultural, servant leadership and focusing on people/teams to drive net promoter scores to all-time highs and enable sustainable long-term success.

Deepak “Dee” Khuntia, M.D., is responsible for leading Varian’s Medical Affairs program. He works closely with the Varian product, regulatory, business development, and innovation teams to provide clinical and scientific guidance in all areas of clinical risk and opportunities, safety reviews, adverse experience reporting, product life cycle reviews, clinical protocol design, mergers and acquisitions, and strategy. Dr. Khuntia joined Varian in 2013. He holds a medical degree from the University of Illinois College of Medicine, and completed his radiation oncology residency at the Cleveland Clinic Foundation.

Vy H. Tran has been with Varian Medical Systems since 1998. While at Varian she has held numerous positions in regulatory affairs and compliance. As a regulatory affairs manager, she was responsible for managing the company’s process for obtaining 510(k) clearances from the U.S. Food and Drug Administration (FDA) for products sold in the United States. Subsequently, as corporate director of regulatory affairs, she managed the global regulatory affairs product submissions process, corporate internal audits and document control. Over the past several years, she has taken on the additional responsibility of becoming the anti-kickback anti-fraud (AKAF) compliance officer and the data privacy officer, establishing and leading the compliance program for both areas.

In her current role as the vice president of regulatory affairs and quality assurance, Tran oversees quality systems compliance, quality assurance, internal audits, document control, post market surveillance reporting and quality systems training for all of the company’s manufacturing sites worldwide. She is also responsible for the regulatory clearance and approval strategies to ensure that new products are accessible to a global market in a timely manner.

Joined Varian as an intern in 1999, then full time in 2001, and has held multiple cross-functional roles and executive positions during two-decade tenure with the company.

Intimate understanding of healthcare, software solutions, medical devices, technology trends, reimbursement trends and strategies that lead to success in targeted channel segments globally. Marketing strategy, new product launch, portfolio strategy, M&A, P&L, restructuring, government relations, and general management experience.

Consistent creation of strategies and execution against operating plans, sales goals and market objectives, including extensive experience of both high growth and slow growth periods (turnaround plans) of Varian Medical Systems journey from $500M to over $3B. Including returning Varian to double digit growth following becoming President of the $3B+ P&L of Oncology systems.

Strong leadership skills with a track record of creating an inspiring vision and communicating effectively both internally/externally through developing cultural, servant leadership and focusing on people/teams to drive net promoter scores to all-time highs and enable sustainable long-term success.